The molecular blueprint of targeted radionuclide therapy
(se abrirá en una nueva ventana)
Autores:
Irina Primac, Kevin Tabury, Alpaslan Tasdogan, Sarah Baatout, Ken Herrmann
Publicado en:
Nature Reviews Clinical Oncology, Edición 22, 2025, ISSN 1759-4774
Editor:
Springer Science and Business Media LLC
DOI:
10.1038/S41571-025-01069-Z
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis
(se abrirá en una nueva ventana)
Autores:
Anita Florit, Elizabeth J. de Koster, Serena Sassano, Lejla Alic, Giusi Pisano, Floris H. P. van Velden, Salvatore Annunziata, Irina Primac, Maria Rosaria Ruggiero, Cristina Müller, Evis Sala, Wolfgang P. Fendler, Giovanni Scambia, Lioe-Fee de Geus-Oei, Anna Fagotti, Vittoria Rufini, Angela Collarino
Publicado en:
European Journal of Nuclear Medicine and Molecular Imaging, Edición 52, 2025, ISSN 1619-7070
Editor:
Springer Science and Business Media LLC
DOI:
10.1007/S00259-025-07277-0